Panic Disorder Market Research Report By Treatment (Medications, Psychotherapy, Cognitive Behavioral Therapy (CBT), Exposure and Response Prevention (ERP)), By Severity (Mild Panic Disorder, Moderate Panic Disorder, Severe Panic Disorder), By Comorbidities (Agoraphobia, Social Anxiety Disorder, Generalized Anxiety Disorder, Depression), By Age Group (Children and Adolescents, Adults, Older Adults) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032

Panic Disorder Market Overview

As per MRFR analysis, the Panic Disorder Market Size was estimated at 10.23 (USD Billion) in 2023. The Panic Disorder Market Industry is expected to grow from 11.42 (USD Billion) in 2024 to 25.38 (USD Billion) by 2032. The Market CAGR (growth rate) is expected to be around 9.28% during the forecast period (2024 - 2032).

Key Panic Disorder Market Trends Highlighted

The leading market trends in the Panic Disorder Market are determined by the growing acceptance of mental Illnesses, increasing attention to panic disorder, and innovative treatment methods. A further positive trend is the elderly population, which is most likely to suffer from mental illnesses. This continues to drive the market. Major players in the market are concentrating on innovative, efficacious treatments, including new drugs and cognitive behavioral therapy, in response to the increasing demand.

The Panic Disorder Market has opportunities for growth owing to the growth overhead and the geographic extension of telemedicine services, which provide an efficient way of care for the individual. Furthermore, using technology or applications for the digital health sector, which helps monitor the symptoms or provide care, will contribute towards improving the patient's response. Work is still being done to develop new types of interventions, including brain stimulation techniques and customization.

Recent developments in the idiopathic panic disorder market include expanding the use of Information and Communication Technologies in the diagnosis and treatment of panic disorders, the availability of internet-based forums to support and offer the patients using a peer-to-peer strategy, and the development of virtual therapy and other engaging treatments. This is indicative of certain changes in the management of panic disorder along the lines of a more efficient approach that is greater flexibility for the patient as well as integration of the deployment of technology.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Panic Disorder Market Drivers

Growing Prevalence of Anxiety Disorders

Panic disorder is a type of anxiety disorder that is characterized by recurrent, unexpected panic attacks. Panic attacks are episodes of intense fear or discomfort that can cause a variety of physical and psychological symptoms, such as chest pain, shortness of breath, dizziness, and nausea. Panic disorder can significantly impair an individual's quality of life and interfere with their ability to work, study, or socialize. The prevalence of anxiety disorders, including panic disorder, has been increasing in recent years.This is likely due to a number of factors, such as the increasing pace of life, the rise of social media, and the growing awareness of mental health issues. As the prevalence of panic disorder continues to increase, so too will the demand for effective treatments. The Panic Disorder Market Industry is expected to grow significantly in the coming years, driven by the increasing prevalence of anxiety disorders. The market is expected to reach a value of USD 3.2 billion by 2032, growing at a CAGR of 4.99% from 2024 to 2032.

Rising Demand for Effective Treatments

At present, there is an increasing demand for effective treatments for panic disorder. It is explained by the growing prevalence of the disorder and its considerable impact on the life of a patient. Traditional treatments for panic attacks are psychotherapy, medication and lifestyle change. Nevertheless, it can be very expensive and time-consuming, and it may not be effective for everybody. Therefore, the past several years have witnessed a rising interest in the use of complementary and alternative medicine, such as acupuncture, yoga and meditation, among others.Usually, this treatment is less expensive and invasive than the traditional one, and it can be effective for some people.

Increasing Awareness of Mental Health Issues

There has been a new consciousness of mental health, including panic disorder. This has come about due to a collection of incidents such as the increasing number of affected people, the more exposure to information, and the rise in openness about feelings. With the rise in awareness of panic disorder, there will also be a need for effective treatment options.

Panic Disorder Market Segment Insights

Panic Disorder Market Treatment Insights

The treatment segment of the Panic Disorder Market is projected to witness significant growth over the forecast period, driven by the increasing prevalence of panic disorder and the availability of a wide range of effective treatment options. Medications, psychotherapy, and cognitive behavioral therapy (CBT) are the primary treatment options for panic disorder. Among these, medications such as selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines are commonly used to alleviate symptoms of anxiety and panic attacks.

Psychotherapy involves talk therapy and counseling sessions, which help individuals understand the underlying causes of their panic disorder and develop coping mechanisms.CBT, a type of psychotherapy, focuses on changing negative thought patterns and behaviors that contribute to panic attacks. Exposure and response prevention (ERP) is another effective treatment for panic disorder. ERP involves gradually exposing individuals to feared situations or objects while teaching them techniques to manage their anxiety and panic responses.

This therapy helps individuals break the cycle of avoidance and fear that often perpetuates panic disorder. The Panic Disorder Market for Medications is anticipated to surpass USD 1.2 billion by 2032, exhibiting a CAGR of around 5.5% during the forecast period.The growing prevalence of panic disorder, coupled with the rising awareness about effective treatment options, is expected to drive the market growth. The Panic Disorder Market for Psychotherapy is projected to reach approximately USD 650 million by 2032, expanding at a CAGR of 4.8% over the forecast period.

The increasing adoption of psychotherapy as a first-line treatment for panic disorder, along with the growing number of qualified mental health professionals, is anticipated to contribute to the market growth. Cognitive Behavioral Therapy (CBT) for Panic Disorder Market is expected to witness robust growth, reaching USD 380 million by 2032, exhibiting a CAGR of 5.2% during the forecast period.The growing recognition of CBT's effectiveness in managing panic disorder, along with the increasing availability of trained therapists, is expected to drive the market growth. Exposure and Response Prevention (ERP) for Panic Disorder Market is projected to reach USD 270 million by 2032, expanding at a CAGR of 4.9% over the forecast period. The growing adoption of ERP as a specialized treatment for panic disorder, along with the increasing number of specialized clinics and trained therapists, is anticipated to contribute to the market growth.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Panic Disorder Market Severity Insights

The Panic Disorder Market is segmented by Severity into Mild Panic Disorder, Moderate Panic Disorder, and Severe Panic Disorder. Among these, the Mild Panic Disorder segment is expected to hold the largest market share, accounting for approximately 45% of the global market revenue in 2023. This is attributed to the higher prevalence of mild panic disorder compared to moderate and severe forms. Moderate Panic Disorder is expected to be the second largest segment, with a market share of around 30% in 2023, followed by Severe Panic Disorder, with a market share of approximately 25%.The market growth for the Severe Panic Disorder segment is anticipated to be the highest during the forecast period, owing to the increasing awareness and diagnosis of panic disorder, leading to a greater demand for effective treatments.

Panic Disorder Market Comorbidities Insights

Comorbidities are common in individuals with panic disorder, with up to 90% experiencing at least one other mental health condition. The most prevalent comorbidities include: Agoraphobia: Fear of open or crowded spaces, affecting an estimated 50-90% of individuals with panic disorder. Social Anxiety Disorder: Excessive fear or anxiety in social situations, affecting approximately 25% of individuals with panic disorder. Generalized Anxiety Disorder: Persistent and excessive worry, affecting around 20% of individuals with panic disorder. Depression: A mood disorder characterized by persistent sadness and loss of interest, affecting an estimated 50-60% of individuals with panic disorder. The presence of comorbidities can significantly impact the severity and course of panic disorder, as well as treatment outcomes. Individuals with comorbid conditions may experience more frequent and severe panic attacks, impaired functioning, and reduced quality of life. Understanding the prevalence and impact of comorbidities is crucial for developing comprehensive treatment plans that address the full spectrum of symptoms and improve patient outcomes.

Panic Disorder Market Age Group Insights

The Panic Disorder Market is segmented by age group into children and adolescents, adults, and older adults. Among these segments, adults hold the largest market share due to the high prevalence of panic disorder in this age group. According to the National Institute of Mental Health, panic disorder affects approximately 2.7% of adults in the United States each year. Children and adolescents are also susceptible to panic disorder, with a prevalence rate of around 1%. Older adults are also at an increased risk of developing panic disorder, as they are more likely to experience physical health conditions that can trigger panic attacks.The Panic Disorder Market is expected to grow significantly in the coming years, driven by factors such as increasing awareness of mental health issues, growing demand for effective treatments, and the development of new medications and therapies.

Panic Disorder Market Regional Insights

The Panic Disorder Market is segmented into North America, Europe, APAC, South America, and MEA. North America held the largest market share in 2023, and is expected to continue to dominate the market throughout the forecast period. The high prevalence of panic disorder in the region, coupled with the increasing adoption of advanced treatment options, is driving the growth of the market in North America. Europe is the second-largest market for panic disorder treatment, and is expected to experience steady growth over the forecast period. The rising awareness about panic disorder and the availability of effective treatment options are contributing to the growth of the market in Europe.The APAC region is expected to witness the fastest growth in the panic disorder market over the forecast period. The increasing prevalence of panic disorder in the region, along with the growing demand for effective treatment options, is driving the growth of the market in APAC. South America and MEA are expected to experience moderate growth in the panic disorder market over the forecast period.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Panic Disorder Market Key Players And Competitive Insights:

Major players in the Panic Disorder Market industry are constantly striving to develop innovative therapies and medications for the treatment of panic disorder. Leading Panic Disorder Market players are actively involved in research and development activities to enhance the efficacy and safety of existing treatments. This competitive landscape is driving the Panic Disorder Market development, leading to the introduction of novel therapies and improved patient outcomes.

The presence of established players and emerging companies in the Panic Disorder Market Competitive Landscape ensures a dynamic and evolving market, fostering continued innovation and advancements in the field. Additionally, strategic partnerships, mergers, and acquisitions among key players are shaping the market landscape, further contributing to the market's growth and consolidation.Pfizer, a leading pharmaceutical company, holds a prominent position in the Panic Disorder Market.

The company's robust portfolio includes medications such as Zoloft (sertraline), which is commonly prescribed for treating panic disorder. Pfizer's extensive research efforts and commitment to developing innovative therapies have solidified its leadership in the market. The company actively engages in clinical trials and collaborations to expand its product offerings and strengthen its market position. Pfizer's strong brand recognition, global presence, and commitment to patient care have contributed to its success in the Panic Disorder Market.Eli Lilly, a multinational pharmaceutical corporation, is another key player in the Panic Disorder Market. The company's portfolio includes Cymbalta (duloxetine), an antidepressant commonly used in the treatment of panic disorder.

Eli Lilly has established a strong presence in the market through strategic partnerships and collaborations with healthcare providers. The company's focus on developing novel therapies and expanding its global reach has positioned it as a formidable competitor in the Panic Disorder Market. Eli Lilly's commitment to patient-centric solutions and its robust research and development pipeline are driving its growth and success in the market.

Key Companies in the Panic Disorder Market Include:

• AstraZeneca PLC


• Johnson Johnson


• Roche Holdings


• Eli Lilly and Company


• Merck Co., Inc.


• Teva Pharmaceutical Industries Ltd


• Sunovion Pharmaceuticals Inc.


• Takeda Pharmaceutical Company Limited


• Sanofi SA


• Allergan


• Lundbeck


• Evotec


• Pfizer Inc.


• BristolMyers Squibb


• Alkermes

Panic Disorder Market Industry Developments

The Panic Disorder therapeutics market is projected to grow from USD 2.07 billion in 2023 to USD 3.2 billion by 2032, at a CAGR of 4.99%. Key factors driving market growth include the increasing prevalence of panic disorder, rising awareness of available treatments, and the introduction of novel therapies. Recent developments in the market include the approval of new drugs such as brexpiprazole and lurasidone, as well as the development of digital therapeutics and virtual reality-based interventions. Key players in the market include Eli Lilly, Pfizer, and Merck Co.

Panic Disorder Market Segmentation Insights